Bextra Side Effects & Recall Lawsuit

Send to Friend | Bookmark | Live Chat

On 4/7/05 the U.S. Food & Drug Administration asked Pfizer, the manufacturer of the Bextra drug, to recall the popular pain medication from shelves across the U.S. due to risks of serious life-threatening side effects including heart attacks, strokes, Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in patients.

Canada Health quickly followed suit and asked Pfizer to recall Bextra from Canadian shelves. In addition, Pfizer has also suspended sales of Bextra in the European Union.

Update: Schmidt & Clark is only accepting Bextra induced SJS cases.

If you or a loved one have taken Bextra and developed SJS, you should contact us immediately. You may be entitled to compensation and we can help.

What is the Problem?

Bextra is in a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). The drug works by reducing substances in the body that cause inflammation, pain, and fever. Bextra is used to reduce pain, inflammation, and stiffness caused by osteoarthritis and adult rheumatoid arthritis. It is also used to treat painful menstruation.

As with all pharmaceuticals, Bextra comes with its list of side effects.

Bextra Side Effects and Recall

The popular painkiller Bextra (Valdecoxib), used by millions of Americans to relieve symptoms of acute arthritis and painful menstrual cycles, may double the risk of heart attacks and strokes.

On April 7, the FDA requested that Pfizer suspend sales in the United States due to the increased risk of cardiovascular events and the development of Stevens Johnson Syndrome and Toxic Epidermal Necrolysis.

Although Pfizer claimed that Bextra was chemically different than Vioxx and did not present the same heart-related risks, Dr. Garret FitzGerald, a cardiologist and pharmacologist at the University of Pennsylvania, presented data in November proving that patients taking Bextra have a 2.19 times greater risk of experiencing a severe coronary event such as a heart attack, stroke or death. According to Dr. FitzGerald,

"The magnitude of the signal with Bextra is even higher than what we saw with Vioxx. This is a time bomb waiting to go off."

Pfizer recently warned doctors that Bextra can cause a rare but dangerous skin reaction called Stevens Johnson Syndrome. Bextra now carries a "black box" warning about these skin reaction risks, which is the final warning step before a recall.

Do I have a Bextra Lawsuit?

The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Bextra lawsuits. We are handling individual litigation nationwide and currently accepting new Bextra cases in all 50 states.

Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.

= Required Field

Bextra Side Effects and Recall / Lawsuit News (National)

Bextra trial delay doesn't sit well with plaintiff - New London Day The woman whose case against Pfizer Inc. over the death of her husband was expected to set the tone for Bextra lawsuits everywhere has not yet received a settlement proposal, her daughter said this week. The Wall Street Journal reported Monday that ... Weitz & Luxenberg Recognizes Asbestos Dangers in Aging School ... - Forbes Weitz & Luxenberg P.C. (weitzlux.com) would like to take a moment during National Teacher Appreciation Week (May 4 - 10) to spotlight the high incidence of asbestos-related mesothelioma among our nation's school teachers in the hope that it will ... Idea AG receives two milestone payments ($37 million) from partner ... - Phramalive.com MUNICH, Germany ? May 7, 2008. IDEA AG today announced that it has received two milestone payments under the US licensing agreement with Alpharma Ireland Limited for Diractin® (ketoprofen in Transfersome®, formerly known as IDEA-033). The total ... Pfizer Incorporated - Orlando Sentinel Erin Casey remembers watching someone freeze racquetballs in liquid nitrogen and throw them against the wall when she was an eighth-grader at Clark Lane Middle School in Waterford. She witnessed this act of scientific violence at the first annual SAM ... Merck & Company Incorporated - Newsday New York-based Pfizer Inc., the world's biggest drugmaker, has started settling cases over its Celebrex and Bextra painkillers, a New York attorney said Friday. The company began negotiating settlements with individual plaintiffs' firms, said David ... Q&A: Post-Vioxx, Pain Relief Remains Complicated - NPR News Vioxx was removed from the market in September 2004 after it was revealed that the drug increased the risk of heart attacks and strokes. Getty Images NPR.org , November 9, 2007 · Merck & Co. said Friday that it will pay nearly $5 billion to end tens ... Beasley Allen Calls for Full Disclosure of Confidential Vioxx ... - PRWeb Co-lead counsel for all Vioxx multi-district litigation believes that the public is entitled to full and complete disclosure of all available and currently protected information regarding the drug's dangers. Montgomery, AL ( PRWEB ) April 29, 2005 ... Possible Painkiller Link to Birth Defects - MedicineNet.com Disordered Eating Is Widespread Among U.S. Women Women Risk Bone Loss After Knee Surgery Baby's Sex May Be Influenced by Mom's Diet Mammograms Still a Good Idea for Elderly Women Pregnancy Risk: Extra Pounds During and Between Aug. 28, 2006 -- Babies ... Beasley Allen Says Bextra Recall May be Too Late for Thousands - PRWeb The Montgomery law firm has filed 161 Bextra, Celebrex and Vioxx lawsuits to date. Montgomery, AL ( PRWEB ) April 15, 2005 -- Law firm Beasley Allen, lead counsel for the first Vioxx lawsuit set for May, believes that Pfizer's Bextra , a COX-2 ... New Painkiller Causes Fewer GI Problems - HealthCentral.com Copyright © 2007 ScoutNews, LLC. All rights reserved. FRIDAY, Feb. 9 (HealthDay News) -- A new cox-2 painkiller called etoricoxib causes fewer upper gastrointestinal problems than the traditional pain medicine diclofenac, researchers report. "In the ...